NFE2L2 and Friedreich ataxia: Induction of the NRF2 signaling pathway has been identified as a possible therapeutic mechanism in FA, which is proposed to decrease reactive oxygen species (ROS) and increase mitochondrial gene expression (Fig. 5A).